d.ferreira
TL2 Moderator · Bochum
Contributes reviews on supplier material. Based in Bochum.
Joined 17 June 2025 · last posted 1d
93 posts, newest first. Showing up to 150.
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #74 · Analytics › HPLC & UHPLC · 27 Jul 2026 · 3 likes Method validation is the demonstration that a method can separate the compound from its degradation products and impurities reliably. A method that cannot resolve an…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #82 · Clinical › Prescriber conversations · 27 Jul 2026 · 1 like Questions about dose: asking "how will we determine whether this dose is working for me" gets at the monitoring plan. Asking "can we start lower" or "can we escalate…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #53 · Compounds › Secretagogues & GH axis · 26 Jul 2026 · 12 likes I read post #51 twice before replying, because I had assumed the opposite. Evidence quality in the secretagogue literature is honestly weaker than in the incretin…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #66 · Compounds › Retatrutide · 16 Jul 2026 · 12 likes How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an effect and is tolerable enough to justify large trials. It does…
-
Immortal time bias in a claims-database study — one year on Replied, post #24 · Evidence › Study critique · 15 Jul 2026 · 11 likes Worth separating two things that post #20 runs together. Building consensus on which criticisms matter: if everyone agrees that the sample size is small but only you…
-
Submitting a sample: the process end to end Replied, post #76 · Sourcing › Independent verification · 12 Jul 2026 · 2 likes Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
-
Heart failure with preserved ejection fraction: symptom endpoints Replied, post #18 · Clinical › Comorbidities · 8 Jul 2026 · 0 likes Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for oral medications and for reconstituted solutions. Discussing specific…
-
How shortages have affected compounding permissions Replied, post #19 · Access › Shortages · 6 Jul 2026 · 32 likes Patient advocacy during shortages: some advocacy groups advocate for patients during shortages. Knowing who they are and following their communication is useful.
-
HbA1c lag and what it can and cannot tell you at eight weeks — one year on Replied, post #16 · Clinical › Bloodwork · 4 Jul 2026 · 0 likes A single value outside interval: usually uninformative on a single draw. What makes a result interesting: a trend across multiple draws, a magnitude well beyond the…
-
Personal or family history of medullary thyroid carcinoma Replied, post #32 · Safety › Contraindications · 30 Jun 2026 · 0 likes Concurrent insulin or sulfonylureas: not an absolute contraindication but requires dose adjustment and close monitoring for hypoglycemia. The combination is used with…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #40 · Access › International · 27 Jun 2026 · 2 likes I read post #38 twice before replying, because I had assumed the opposite. Customs and import outcomes: different routes have different seizure rates. Some countries…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #127 · Practice › Storage & stability · 10 Jun 2026 · 1 like Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing for long periods and light matters, this is worth doing. For…
-
Reading a trial's population section before its results Replied, post #90 · Evidence › Trials · 5 Jun 2026 · 0 likes Coming back to post #88, because the follow-up matters more than the original answer. Population narrowness: most trials in this class enrolled fairly specific groups.…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #83 · Practice › Reconstitution · 1 Jun 2026 · 2 likes This follows post #80 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #7 · Compounds › Tirzepatide · 29 May 2026 · 0 likes I read post #5 twice before replying, because I had assumed the opposite. Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you…
-
The anatomy of a question that gets answered within an hour Replied, post #58 · Start Here › How to Ask · 27 May 2026 · 0 likes Context that matters: compound, how long in, current dose, relevant history. Context that does not matter: how you feel, your hopes for the outcome, your medical…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #68 · Practice › Reconstitution · 23 May 2026 · 27 likes On post #64 — agreed on the reasoning, with one qualification. A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some…
-
A checklist for reading a certificate in under two minutes Replied, post #21 · Analytics › COA interpretation · 15 May 2026 · 16 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
About the Insurance & coverage category Replied, post #5 · Access › Insurance & coverage · 30 Apr 2026 · 13 likes Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite specific criteria. Understanding the criterion is the first step in satisfying…
-
Comparing documentation quality across the directory, tabulated Started this topic · Sourcing › Vendor reports · 29 Apr 2026 · 1 like Comparing documentation quality across the directory, tabulated — setting out what I have, and where I think it stops being reliable. I would like to talk about…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #42 · Sourcing › Independent verification · 28 Apr 2026 · 30 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Coming back to: Reconciling a supplier certificate with an independent result Started this topic · Sourcing › Vendor reports · 28 Apr 2026 · 10 likes Posting this under the heading it deserves: Reconciling a supplier certificate with an independent result Everything below is what sits behind that. Structured report…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #60 · Devices › Syringes & needles · 25 Apr 2026 · 14 likes post #59 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #79 · Analytics › Mass spectrometry · 13 Apr 2026 · 0 likes Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal. Report whether desalting was used, because it can affect the…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #108 · Clinical › Special populations · 13 Apr 2026 · 25 likes Picking up post #105: that is the part I would want checked first. Renal impairment: the compounds are cleared renally to some degree. Dose adjustments might be needed…
-
The "under review" status pill and when a moderator applies it Replied, post #42 · Evidence › Preprints · 28 Mar 2026 · 0 likes On post #38 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
The lowest dose that does anything: is that a real question? Replied, post #108 · Practice › Dosing & titration · 8 Mar 2026 · 18 likes post #107 is right about the mechanism and I think understates the practical bit. Titrating on tolerability rather than on the calendar: some people escalate when they…
-
[2026 update] What a purity-only report leaves out Replied, post #39 · Sourcing › Independent verification · 1 Mar 2026 · 0 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
-
Why one laboratory's 98.4% and another's 96.1% may not contradict — one year on Replied, post #10 · Analytics › Method validation · 21 Feb 2026 · 0 likes I read post #8 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #35 · Practice › Dosing & titration · 16 Feb 2026 · 25 likes This follows post #32 rather than contradicting it. Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives.…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #109 · Access › International · 14 Feb 2026 · 24 likes On post #105 — agreed on the reasoning, with one qualification. Country-by-country legality: compound approval and legal status differ substantially by jurisdiction.…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #64 · Compounds › Semaglutide · 6 Feb 2026 · 0 likes Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they stopped at 2.4 mg. Some people report trying higher doses, but…
-
MHRA statements, read directly Replied, post #67 · Regional › UK & Ireland · 13 Jan 2026 · 1 like Private prescribing is legal and widespread, including through remote consultation. Pharmacies must satisfy themselves that a prescription is clinically appropriate.…
-
Personal import allowances, compared — a second dataset Replied, post #47 · Access › International · 5 Jan 2026 · 27 likes Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is not approved, the legality of possession and use is…
-
[2026 update] What a good consultation looks like from the other side Replied, post #10 · Clinical › Prescriber conversations · 4 Jan 2026 · 27 likes Picking up post #7: that is the part I would want checked first. What to bring: copies of relevant lab results, pharmacy records (to confirm doses actually taken), and…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #38 · Clinical › Bloodwork · 27 Dec 2025 · 12 likes post #37 is right about the mechanism and I think understates the practical bit. Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age,…
-
Request declined, with reasoning — what changed since Replied, post #2 · Meta › Feature requests · 25 Dec 2025 · 12 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #42 · Pharmacology › Pharmacokinetics · 21 Dec 2025 · 5 likes Hepatic metabolism: the degree to which each compound is hepatically metabolised versus renally cleared is known but varies. Severe liver disease changes clearance.
-
Heterogeneity as information rather than as a nuisance Replied, post #27 · Evidence › Meta-analyses · 16 Dec 2025 · 9 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Reused chromatograms across lots: how to spot it Replied, post #8 · Analytics › COA interpretation · 14 Dec 2025 · 0 likes Worth separating two things that post #4 runs together. Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the…
-
What pooling buys you and what it destroys Replied, post #76 · Evidence › Meta-analyses · 26 Nov 2025 · 7 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #26 · Sourcing › Regulatory · 12 Nov 2025 · 15 likes Off-label use and medical practice: clinicians can prescribe approved medications off-label under some circumstances. That is different from research-use-only…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #53 · Start Here › How to Ask · 3 Nov 2025 · 14 likes The specific question in the title is more useful than you might think. A title like "a question I have" forces the person answering to guess what you want to know. A…
-
Sleep quality changes during weight loss — what changed since Replied, post #34 · Wellbeing › Sleep · 21 Oct 2025 · 3 likes Gastrointestinal effects overnight: nausea or reflux or constipation at night can disrupt sleep. Dosing timing (morning versus evening) might help if nighttime GI…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #10 · Clinical › Special populations · 8 Oct 2025 · 1 like Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning windows (how long to wait before attempting pregnancy) are not formally…
-
What pooling buys you and what it destroys Replied, post #36 · Evidence › Meta-analyses · 6 Oct 2025 · 8 likes Funnel plots: a plot of study effect size versus sample size that helps detect publication bias. If small studies are missing on the negative side, the funnel is…
-
What a purity-only report leaves out Replied, post #31 · Sourcing › Independent verification · 1 Oct 2025 · 0 likes On post #27 — agreed on the reasoning, with one qualification. Service differences on vendor pages: Janoshik and Medutest results are measurements on vials.…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #50 · Lounge › Off topic · 22 Sep 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Substitution between formats during a shortage Replied, post #59 · Access › Shortages · 18 Sep 2025 · 15 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #117 · Access › Insurance & coverage · 12 Sep 2025 · 0 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #123 · Data & Tools › Datasets · 11 Sep 2025 · 6 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
A ten-fold dose error caught before injection Replied, post #95 · Devices › Syringes & needles · 6 Sep 2025 · 14 likes Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL. Always confirm your syringe is U-100. Confusion between insulin units and…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #52 · Evidence › Journal club · 27 Aug 2025 · 9 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #14 · Evidence › Journal club · 11 Aug 2025 · 15 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
-
A request that was declined, and the reasoning — a second dataset Replied, post #9 · Documentation › Wiki requests · 5 Aug 2025 · 8 likes Worth separating two things that post #5 runs together. Accessibility feedback: if you have trouble accessing or reading a maintained page (screen reader issues,…
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #12 · Compounds › Other compounds · 4 Aug 2025 · 0 likes post #11 answers the question as asked. The question underneath it is different. Reading a supplier's product description as a marketing document: that is exactly what…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #156 · Devices › Cold chain · 4 Aug 2025 · 7 likes Reconstituted solutions: once reconstituted, solutions are less stable than lyophilised powder. Refrigerate prepared solutions immediately after preparation. Most…
-
How to research a compound with no human data without deceiving yourself Replied, post #90 · Compounds › Other compounds · 3 Aug 2025 · 0 likes Coming back to post #88, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
When a preprint is the best available evidence and we say so Replied, post #17 · Evidence › Preprints · 2 Aug 2025 · 0 likes On post #13 — agreed on the reasoning, with one qualification. How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #10 · Analytics › COA interpretation · 22 Jul 2025 · 32 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
-
Meeting a protein target on a suppressed appetite Replied, post #9 · Nutrition & Training › Protein & intake · 11 Jul 2025 · 4 likes Leucine and MPS: leucine stimulates muscle protein synthesis at a threshold of roughly 2 to 3 grams per meal. That influences how much protein per meal matters, but…
-
Coming back to: Oxidation and deamidation mass shifts, tabulated Replied, post #17 · Analytics › Mass spectrometry · 29 Jun 2025 · 0 likes Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at m/z ≈ 2057, triply charged at ≈ 1371, quadruply at ≈ 1029. Those are the positions…
-
Repeatability versus intermediate precision Replied, post #78 · Analytics › Method validation · 27 Jun 2025 · 28 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #56 · Compounds › Cagrilintide & amylin analogues · 16 Jun 2025 · 0 likes Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct mechanisms. Whether the slowing at a higher magnitude produces disproportionate…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #108 · Compounds › Tirzepatide · 12 Jun 2025 · 0 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #48 · Evidence › Journal club · 10 Jun 2025 · 14 likes I read post #46 twice before replying, because I had assumed the opposite. Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #82 · Practice › Reconstitution · 7 Jun 2025 · 10 likes Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #97 · Wellbeing › Mental health · 3 Jun 2025 · 1 like Coming back to post #95, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
A claim built entirely on a subgroup analysis Replied, post #66 · Evidence › Study critique · 31 May 2025 · 4 likes What makes a methodological criticism substantive: it identifies a specific feature of the design that materially affects what the paper can conclude. "Small sample…
-
Revisiting: German, French and Dutch differences, compared Replied, post #26 · Regional › European Union · 27 May 2025 · 0 likes Cross-border purchase rules: buying a prescription in one EU country and bringing it home is complex. The substance is legal but crossing borders with it requires…
-
Request: a diff view for wiki revisions — the long version Replied, post #4 · Meta › Feature requests · 26 May 2025 · 1 like Feature scope: some requests are for the site itself (search, filtering, navigation). Some are for the documentation (new topics, different formats). Scope helps…
-
Reading a regulatory notice rather than an article about it — what changed since Replied, post #7 · Sourcing › Regulatory · 24 May 2025 · 3 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption. The…
-
Half-life, steady state, and accumulation worked through Replied, post #10 · Pharmacology › Pharmacokinetics · 22 May 2025 · 0 likes post #9 is right about the mechanism and I think understates the practical bit. Fasting requirement for oral semaglutide: food and large fluid volumes reduce…
-
Pregnancy as an absolute contraindication Replied, post #63 · Safety › Contraindications · 19 May 2025 · 8 likes Concurrent insulin or sulfonylureas: not an absolute contraindication but requires dose adjustment and close monitoring for hypoglycemia. The combination is used with…
-
Second pass at: Designing a personal experiment that could change your mind Replied, post #11 · Research Methods › N-of-1 designs · 17 May 2025 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
A report I filed that turned out to be wrong, and the correction Replied, post #43 · Sourcing › Vendor reports · 7 May 2025 · 1 like Worth separating two things that post #39 runs together. Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined purity and…
-
When to stop reading forums, including this one — the long version Replied, post #4 · Wellbeing › Mental health · 28 Apr 2025 · 25 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Micronutrient status when intake falls substantially — a second dataset Replied, post #13 · Clinical › Bloodwork · 28 Apr 2025 · 17 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Follow-up: Journal club: the retatrutide phase 2 obesity paper Replied, post #23 · Evidence › Journal club · 8 Apr 2025 · 3 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
What happens after your first post: likes, trust levels, and why none of it matters much Replied, post #11 · Start Here › Welcome · 26 Mar 2025 · 0 likes Worth separating two things that post #7 runs together. There is no stupid-questions rule and no penalty for asking badly. The response to a poorly framed question is a…
-
How compounding permissions changed when supply normalised Replied, post #26 · Sourcing › Regulatory · 4 Mar 2025 · 5 likes Off-label use and medical practice: clinicians can prescribe approved medications off-label under some circumstances. That is different from research-use-only…
-
Validating a method you did not develop — does this still hold? Replied, post #69 · Analytics › Method validation · 4 Mar 2025 · 0 likes On post #65 — agreed on the reasoning, with one qualification. System suitability: injections run at the start of a batch to establish that the instrument and column…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #86 · Compounds › Semaglutide · 3 Mar 2025 · 5 likes I read post #84 twice before replying, because I had assumed the opposite. The mass figure differs between sources because of how the different entities report it. The…
-
Reading an MS report that only gives you a single number Replied, post #19 · Analytics › Mass spectrometry · 28 Feb 2025 · 19 likes Sample matrix effects: if a sample is dissolved in a complex matrix, other compounds in the matrix can suppress the peptide signal. Clean samples give higher…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #66 · Compounds › Cagrilintide & amylin analogues · 15 Feb 2025 · 6 likes Historical amylin analogues: pramlintide was the only long-acting amylin analogue licensed for some time and its poor adherence was a known limitation. A weekly…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #78 · Compounds › Oral incretins · 27 Dec 2024 · 0 likes Coming back to post #76, because the follow-up matters more than the original answer. PIONEER programme is phase 3 for oral semaglutide. The trials cover multiple…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #35 · Compounds › Semaglutide · 20 Dec 2024 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Reading a supplementary appendix and finding the interesting part Replied, post #44 · Evidence › Trials · 15 Dec 2024 · 0 likes This follows post #41 rather than contradicting it. Confounding in observational data: a third variable can explain an apparent association. In a randomised trial,…
-
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #45 · Meta › Wiki maintenance · 23 Nov 2024 · 0 likes This follows post #42 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #14 · Sourcing › Red flags · 10 Nov 2024 · 11 likes Safety documentation absent: a supplier that cannot provide information about sterility testing, endotoxin testing, or safety documentation when asked is raising flags.
-
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #23 · Sourcing › Regulatory · 7 Nov 2024 · 3 likes Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if ingested. It changes the legal status of the sale. The labelling…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #73 · Sourcing › Independent verification · 20 Sep 2024 · 12 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #34 · Compounds › Semaglutide · 3 Sep 2024 · 17 likes I read post #32 twice before replying, because I had assumed the opposite. Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and…